Researchers at ETH Zurich combined two CRISPR-Cas methods to decipher how mutations in a cell’s genome affect its function.

It might be possible for people in the future to consume BHB-Phe to drive weight loss without restricting carbohydrates in ...

Lonza offers customers a fully integrated solution, spanning design and lead molecule generation, including Synaffix ...

Novel method identified protein degraders that target Pin1, a protein involved in pancreatic cancer development.

The topline data showed ISM001-055 to have improved the forced vital capacity (FVC) of IPF patients studied 12 weeks after ...

Studies suggest the cell is more interconnected than previously thought, opening up "exciting possibilities for science and medicine." ...

Regular activity not only strengthens muscles but can bolster our bones, blood vessels, and immune system. MIT engineers have now found that exercise can also have benefits at the level of individual ...

National Institutes of Health (NIH) scientists and collaborators say they have discovered a new way in which RAS genes, ...

Scale Bio names winning projects for the 100M cell challenge across diverse applications, from global health initiatives to ...

At ASHG, Seer showcased its Proteograph product suite which it claims delivers proteomic insights that complement and ...

A trio of stock analysts this week examined the likely impacts on biopharma from Donald Trump’s election victory and ...

The most important takeaway from the study is that these data suggest that CD47 is an attractive target for drug development.